Supporting the Rise of Cell & Gene Therapies – UK and New Jersey Perspectives

You CANNOT complete an online booking for colleagues for this event. Tuesday 3 November 15:00-16:15

Registration is now closed. Please email to be added to the waitlist.

Cell and gene therapies are here to stay as medicines that are helping to provide opportunities to patients with high unmet medical need.  Whilst an exciting environment, there are many challenges with innovation and commercialisation to be overcome.  Collaboration, no doubt, will help to overcome some of these.  In this session there will be a facilitated Q&A with leading executives from New Jersey and the UK discussing the current landscape, challenges and opportunities in the field of cell and gene therapies.  This will be followed by a breakout session were there will be further chance for delegates to make introductions and discuss the key points raised in the preceding fireside chat. 


15.00 – Welcome from One Nucleus, BioNJ and Choose New Jersey

15.10 – Meet the KOL fireside chat


Dr Tony Jones, CEO, One Nucleus

Dr Anne Lane, CEO, UCLB
Dr Stuart Peltz, CEO, PTC Therapeutics


15.40 – Breakout Networking

16.00 – Return to the main room for closing poll

16.10 – Poll results and closing remarks

16.15 – Close


November 3rd, 2020 3:00 PM   to   4:15 PM
Belgium Embassy, 17, Grosvenor Crescent
London, SW1X 7EE
United Kingdom
Phone: 01223 896450
Phone: 01223 896456
Email: Email:

Help spread the word

Please help us and let your friends, colleagues and followers know about our page: Supporting the Rise of Cell & Gene Therapies – UK and New Jersey Perspectives

You can also share the below link in an email or on your website.